Not On My Watch – Dr. Arjun Gupta
Dr Arjun Gupta discusses a 'Cancer Care Chronicles' essay he published in JAMA Oncology, titled ''Not On My Watch.'' In the essay, he shares his… Read More »Not On My Watch – Dr. Arjun Gupta
Dr Arjun Gupta discusses a 'Cancer Care Chronicles' essay he published in JAMA Oncology, titled ''Not On My Watch.'' In the essay, he shares his… Read More »Not On My Watch – Dr. Arjun Gupta
A national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019. Elizabeth Platz, M.P.H.,… Read More »Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention
Members of the Johns Hopkins Melanoma Program participated in an annual 5K walk/run event and received funds raised by the event during a visit in… Read More »Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins
Our collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory… Read More »Pancreatic Cancer Matters: Right Treatment at the Right Time
Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances… Read More »The Future of Pancreatic Cancer Treatments
A guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly… Read More »Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important… Read More »Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for… Read More »Three Minutes with Oncologist Michael Carducci
Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and… Read More »Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of… Read More »Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers